1. Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA1c in Andalusia (Spain): PLATEDIAN Study
- Author
-
Ruiz de Adana, Maria S, Alhambra-Expósito, Maria Rosa, Muñoz-Garach, Araceli, Gonzalez-Molero, Inmaculada, Colomo, Natalia, Torres-Barea, Isabel, Aguilar-Diosdado, Manuel, Carral, Florentino, Serrano, Manuel, Martínez-Brocca, Maria A, Duran, Ana, Palomares, Rafael, Diabetes Group of SAEDYN (Andalusian Society of Endocrinology, Diabetes, and Nutrition), Sociedad Andaluza de Endocrinología, Diabetes y Nutrición, and Ministerio de Economía y Competitividad (España)
- Subjects
Adult ,Blood Glucose ,Male ,Research design ,medicine.medical_specialty ,Office Visits ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,030209 endocrinology & metabolism ,Injections ,law.invention ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,Quality of life ,law ,Internal medicine ,Diabetes mellitus ,Internal Medicine ,medicine ,Humans ,Hypoglycemic Agents ,Insulin ,030212 general & internal medicine ,Young adult ,Glycated Hemoglobin ,Advanced and Specialized Nursing ,Type 1 diabetes ,Dose-Response Relationship, Drug ,Primary Health Care ,business.industry ,Middle Aged ,medicine.disease ,Hypoglycemia ,Telemedicine ,Diabetes Mellitus, Type 1 ,Treatment Outcome ,Spain ,Metabolic control analysis ,Quality of Life ,Female ,business ,Follow-Up Studies - Abstract
Diabetes Group of SAEDYN (Andalusian Society of Endocrinology, Diabetes, and Nutrition)., [Objective] To assess the impact of a telemedicine visit using the platform Diabetic compared with a face-to-face visit on clinical outcomes, patients’ health-related quality of life (HRQoL), and physicians’ satisfaction in patients with type 1 diabetes., [Research design and methods] PLATEDIAN (Telemedicine on Metabolic Control in Type 1 Diabetes Mellitus Andalusian Patients) (NCT03332472) was a multicenter, randomized, 6-month follow-up, open-label, parallel-group controlled study performed in patients with type 1 diabetes with suboptimal metabolic control (HbA1c, [Results] At month 6, the mean change in HbA1c levels was −0.04 ± 0.5% (−0.5 ± 5.8 mmol/mol) in the CC and 0.01 ± 0.6% (0.1 ± 6.0 mmol/mol) in the IC (P = 0.4941). The number of patients who achieved HbA1c, [Conclusions] The use of telemedicine in patients with type 1 diabetes with HbA1c, This study was sponsored by the Andalusian Society of Endocrinology, Diabetes, and Nutrition (SAEDYN). A.M.-G. was the recipient of a postdoctoral grant (Juan Rodes JR 17/00023) from the Spanish Ministry of Economy and Competitiveness.
- Published
- 2020